-
Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'
Monday, December 5, 2022 - 9:23am | 233Read More...The iShares Biotechnology ETF (NASDAQ: IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to around 10%. On CNBC’s “Halftime Report Final Trades,” Jeffrey Mills of Bryn Mawr Trust recommended going long on biotech stocks. Check out...
-
Analyst Recommends 3M And Caterpillar (MMM, CAT, CSCO, ATT)
Friday, June 18, 2010 - 1:21pm | 153Read More...Chip Cobb, senior vice president at Bryn Mawr Trust, discussed his market outlook with CNBC. He said, “Unfortunately, we’re stuck in a trading range and I think we’re going to be here for a while. Primarily, there’s a lot of pressure that we’re dealing with and most of it is headline risk.” He said...
